The Mosaic Company reported fourth-quarter net income down 79%, as falling prices for crop nutrients potash and phosphate ate into profits. Per-share earnings of 30 cents fell short of consensus by 14 cents a share. However, profitability concerns aren't making a dent in investor appetite. Shares are up after the board approved a $1 billion share repurchase program. Management already approved a buyback program in December which would see the company repurchase 43.4 million Class A shares within the first seven months of 2014.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.